Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Propranolol in pregnancy three year prospective study.

I Livingstone, P W Craswell, E B Bevan

    Clinical and Experimental Hypertension. Part B, Hypertension in Pregnancy
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Neurological factors and Cesarean section in Australian women with epilepsy.

    Epilepsy & behavior : E&B·2022
    Same author

    Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register.

    Seizure·2018
    Same author

    Antiepileptic drug polytherapy in pregnant women with epilepsy.

    Acta neurologica Scandinavica·2018
    Same author

    Predicting epileptic seizure control during pregnancy.

    Epilepsy & behavior : E&B·2017
    Same author

    Anti-epileptic drug exposure and risk of foetal death in utero.

    Acta neurologica Scandinavica·2017
    Same author

    Triptan use in Australia 1997-2015: A pharmacoepidemiological study.

    Acta neurologica Scandinavica·2017

    Propranolol and methyldopa equally control pregnancy-associated hypertension. However, propranolol use in mothers resulted in one infant with symptomatic hypoglycemia, and its metabolites transfer to breast milk.

    Area of Science:

    • Pharmacology
    • Obstetrics
    • Neonatology

    Background:

    • Pregnancy-associated hypertension is a common complication.
    • Beta-blockers like propranolol are used to manage hypertension during pregnancy.
    • Methyldopa is another commonly used antihypertensive agent in pregnancy.

    Purpose of the Study:

    • To compare the efficacy and safety of propranolol versus methyldopa in managing pregnancy-associated hypertension.
    • To assess maternal and neonatal outcomes in a randomized prospective study.

    Main Methods:

    • A randomized prospective study involving 28 women with pregnancy-associated hypertension.
    • Comparison of propranolol and methyldopa for hypertension control.
    • Evaluation of maternal hypertension, infant birthweights, and infant blood glucose levels.

    Related Experiment Videos

  • Analysis of propranolol and its metabolites in maternal plasma and breast milk across trimesters and postpartum.

    • Main Results:

    • Both propranolol and methyldopa were equally effective in controlling maternal hypertension.
    • No significant difference in infant birthweights between the two groups.
    • One infant born to a mother on propranolol experienced symptomatic hypoglycemia.
    • Propranolol and its metabolites cross into breast milk, with estimated infant intake being approximately 0.1% of the maternal dose.
    • Naphthoxylactic acid levels were significantly lower in the third trimester compared to postpartum.

    Conclusions:

    • Propranolol and methyldopa demonstrate comparable efficacy in treating pregnancy-associated hypertension.
    • While generally safe, propranolol use may be associated with a risk of symptomatic hypoglycemia in neonates.
    • The transfer of propranolol and its metabolites into breast milk is minimal, suggesting a low risk for breastfeeding infants.